Merrell Pharmaceuticals, Inc.

Merrell Dow Pharmaceuticals

Celine Tarnus

Viviane Van Dorsselaer

Daniel G Schirlin

Daniel Schirlin

Robert J Broersma

Bernhard Neises

Hugues D'Orchymont

Axel Ganzhorn

Robert A Farr

Robert J Cregge

David A Janowick

Daniel T Kohlman

This invention relates to novel difluoro statone analogs, to the processes and intermediates useful for their preparation and to their use as anti-viral agents.

Difluoro statone analogs

This invention relates to novel statone antiviral analogs, to the processes and intermediates useful for their preparation and to their use as antiviral agents.

Difluoro statone antiviral analogs

This invention relates to novel difluoro statone analogs, to the processes and intermediates useful for their preparation and to their use as anti-vital agents.

Anti-viral compounds

This invention relates to novel polyfluorinated alkyl derivatives of certain tripeptides, to the methods for their preparation, the intermediates therefore, to their use in inhibiting thrombin and lung tryptase and in their end-use application as anti-coagulants useful in treating thrombophlebitis and coronary thrombosis and in the treatment of asthma.

Thrombin inhibitors

Polyfluorinated tripeptide thrombin inhibitors

This invention relates to novel derivatives of tetralin, to the processes for their preparation, to their use as amino-peptidase inhibitors and to their end-use application as immunomodulators and as analgesic agents.

Method of using certain tetralin derivatives to produce analgesic relief

This invention relates to novel derivatives of tetralin, to the processes for their preparation, to their use as aminopeptidase inhibitors and to their end-use application as immunomodulators and as analgesic agents.

Growing community of inventors

Strasbourg, France

Celine Tarnus